Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Bussel

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Blood|August 4, 2012
Defective regulatory B-cell compartment in patients with immune thrombocytopeniaXiaojuan Li, Hui Zhong, Weili Bao, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2007
Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotesLi Zhang, Lin Radigan, Ulrich Salzer, et al.
Blood|April 28, 2006
Correction of a murine model of von Willebrand disease by gene transferRobert G Pergolizzi, Guangchun Jin, Diane Chan, et al.
Blood|November 9, 2002
Two novel mutations in the alpha IIb calcium-binding domains identify hydrophobic regions essential for alpha IIbbeta 3 biogenesisW Beau Mitchell, Ji Hong Li, Fiza Singh, et al.
Blood Advances|April 12, 2022
A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopeniaJohn Grainger, James Bussel, Michael Tarantino, et al.
British Journal of Haematology|June 8, 2019
FAS mutations are an uncommon cause of immune thrombocytopenia in children and adults without additional features of immunodeficiencyJana Vandrovcova, Ulrich Salzer, Bodo Grimbacher, et al.
Pediatric Blood & Cancer|September 13, 2011
Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP)Robert J Klaassen, Susan D Mathias, George Buchanan, et al.
British Journal of Haematology|April 26, 2002
Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopeniaSonja van den Oudenrijn, Marrie Bruin, Claudia C Folman, et al.
Journal of Pediatric Hematology/Oncology|January 25, 2003
Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parentsDorothy Barnard, Michael Woloski, David Feeny, et al.
British Journal of Haematology|June 10, 2025
Increased ultra-large von Willebrand factor multimers in immune thrombocytopeniaLamya Garabet, Waleed Ghanima, James Bussel, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Blood|August 4, 2012
Defective regulatory B-cell compartment in patients with immune thrombocytopeniaXiaojuan Li, Hui Zhong, Weili Bao, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2007
Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotesLi Zhang, Lin Radigan, Ulrich Salzer, et al.
Blood|April 28, 2006
Correction of a murine model of von Willebrand disease by gene transferRobert G Pergolizzi, Guangchun Jin, Diane Chan, et al.
Blood|November 9, 2002
Two novel mutations in the alpha IIb calcium-binding domains identify hydrophobic regions essential for alpha IIbbeta 3 biogenesisW Beau Mitchell, Ji Hong Li, Fiza Singh, et al.
Blood Advances|April 12, 2022
A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopeniaJohn Grainger, James Bussel, Michael Tarantino, et al.
British Journal of Haematology|June 8, 2019
FAS mutations are an uncommon cause of immune thrombocytopenia in children and adults without additional features of immunodeficiencyJana Vandrovcova, Ulrich Salzer, Bodo Grimbacher, et al.
Pediatric Blood & Cancer|September 13, 2011
Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP)Robert J Klaassen, Susan D Mathias, George Buchanan, et al.
British Journal of Haematology|April 26, 2002
Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopeniaSonja van den Oudenrijn, Marrie Bruin, Claudia C Folman, et al.
Journal of Pediatric Hematology/Oncology|January 25, 2003
Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parentsDorothy Barnard, Michael Woloski, David Feeny, et al.
British Journal of Haematology|June 10, 2025
Increased ultra-large von Willebrand factor multimers in immune thrombocytopeniaLamya Garabet, Waleed Ghanima, James Bussel, et al.
Pageof 6